Medical News arrow Home
Home
Australians will be screened for Bowel Cancer
User Rating: / 0
Written by Dr Margaret   
Feb 27, 2008 at 04:48 AM

The Australian Government conducted a pilot screening program for Colon(Bowel) Cancer between  January 2001 and June 2004 using faecal blood testing, and plans are now underway to screen the rest of us using this non-invasive test.

Australia has one of the highest rate of bowel cancer in the world , being the most common cancer affecting both men and women, and the second most common cancer related death after lung cancer.  The study was done after international studies demonstrated that screening using Faecal occult Blood(FOBT) using Immunochemical analysis can reduce mortality from bowel cancer from 15-33% to assess whether it was feasible and costeffective in Australia. The report on the pilot study of patients aged between 55 and 74years using biennial FOBT  with the Health Department developing a Bowel Cancer Screening Register. Personal invitations were sent to those in the target group. (At age 100 years you get a congratulatory letter from the Queen, but the first milestone is a letter from the Government when you turn 55 inviting you to poo in a pot).

The results demonstrated that of the 25600 people sampled, 9.1% returned a positive FOBT . On those who had a positive FOBT and proceeded to full large bowel examination with colonoscopy 19.2% were found to have a suspected bowel cancer or advanced adenoma(pre-maliganant tumour). Australian states will now be conducting ongoing screening for Bowel Cancer, and it is hoped people will be sensible enough to participate in the programme  when their invitation arrives. The evidence shows it is effective at reducing mortality from bowel cancer

Write Comment (0 comments)
Last Updated ( Feb 27, 2008 at 04:49 AM )
Relatives of patients with premature Heart Disease at Increased Risk
User Rating: / 0
Written by Dr Margaret   
Feb 22, 2008 at 02:49 AM
From the BRITISH MEDICAL JOURNAL (BMJ) September 8,2007   First degree relatives of patients with premature coronary heart disease are at increased risk of having an early Heart Attack alsoz. Compared with the general population, siblings have at least double the risk, because of shared lifestyle risk factors and genetic predisposition. Offspring and partners are also at increased risk. Relatives have an increased prevalence of modifiable risk factors including high Blood Pressure, high cholesterol, and smoking. Some guidelines recommend screening of relatives, but surveys indicate that this does not occur in practice.

Researchers from the University of Glasgow looked at data from previous studies which show that immediate family members of patients with premature coronary heart disease (CHD) are at significantly increased risk of developing the disease.

Siblings are twice as likely to have a heart attack compared to the general population. Partners are also known to be at greater risk, due to shared risk factors in their lifestyle. The risk to family members increases further if more than one member of the immediate family has CHD.

Family history, the researchers say, can identify a large percentage of people at high overall risk of developing CHD. One study found that the 14% of families with a positive family history accounted for 48% of all CHD events and 72% of all premature deaths.

Using data from previous studies they estimate that in England and Scotland alone 7,369 premature heart attacks occur each year in people with a family history of premature heart attacks. Of those 6,485 might be preventable.

Once the risk of having a family member with CHD(Coronary Heart Disease) was taken into account they calculated that screening and treating middle aged adults with a family history could have prevented 42% of premature heart attacks and 8% of all heart attacks.

Many of the factors which increase the chances of developing Coronary Artery Disease are remediable, for example, smoking or having high blood pressure. Researchers recommend  family members  would benefit interventions to reduce these risks.

There have been attempts to identify high risk families via school, work or on-line questionnaires in the past, but the researchers believe “wide coverage could be achieved by identifying relatives whenever someone is admitted to hospital for premature heart attack. Furthermore they may be motivated by their relative’s illness, thereby improving the attainment and maintenance of risk factor control.”

Patients with CHD usually present to an Emergency Department or are referred to an outpatient clinic. These patients, they say, could be flagged as requiring family counselling. They conclude immediate family are an obvious, but neglected group at which primary prevention should be targeted.

Recommendations by Dr Chow and colleagues are summarised below:

  • Prevention of coronary heart disease is most effective if targeted at people with high of

overall risk

 First degree relatives of patients with premature myocardial infarction have double the risk of the condition
In the UK, about 20% of all admissions for myocardial infarction occur in patients with premature myocardial infarction
More than a third of admissions for premature myocardial infarction could be prevented by screening and treating first degree relatives

The researchers who published the article were

C K Chow, cardiology research fellow1, A C H Pell, consultant cardiologist2, A Walker, health economist3, C O'Dowd, health economist3, A F Dominiczak, professor of cardiovascular medicine1, J P Pell, professor of epidemiology1

1 BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow G12 8TA, 2 Monklands Hospital, Airdrie, 3 Robertson Centre for Biostatistics, University of Glasgow

Last Updated ( Mar 15, 2008 at 03:47 PM )
Sleeping Pill Stilnox to Stay
User Rating: / 0
Written by Dr Margaret   
Nov 19, 2005 at 07:52 AM

Sleeping pill Zolpidem(Stilnox) was the subject of a review with the National Drugs and Poisons Schedule this week where consideration was given to reschedule it to Schedule 8 where the drugs of addiction are sceduled. Much media publicity has been received due to reported bizarre sleep reactions.  The committe decided to leave the drug as a Schedule 4 presciption medication along with the majority of other prescription pills.  It was concluded that Stilnox did not meet the criteria for a schedule 8 medication which must show substantial risk of abuse,dependence or misuse for illegal purposes. Rohypnol, a powerful sleeping pill known as the "date-rape drug" was rescheduled as a Schedule 8 some years ago which reduced its use and abuse within the community considerably. 

Stilnox is available in Australian pharamcies on a private prescription from a doctor , with no PBS subsidy available in Australia. Stilnox regular 10mg tablets are presented in packs of 7 and 20, while Stilnox CR(a modified sustained release preparation) is available in strengths of 6.25mg and 12.5mg in quantities of 21 tablets. Generic Zolpidem is available as the brand Stildem.

Last Updated ( Feb 25, 2008 at 12:00 AM )
Read more...
<< Start < Previous 1 2 3 4 5 Next > End >>

Results 19 - 24 of 25